Cysteine delivery system

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31195

Patent

active

044381247

ABSTRACT:
L-2-oxothiazolidine-4-carboxylate, a sulfur analog of 5-oxoproline, is cleaved by the enzyme 5-oxo-L-prolinase to form cysteine, thus providing the basis for a cysteine delivery system by the addition of L-2-oxothiazolidine-4-carboxylate to base amino acid solutions or by injecting it directly into in vivo cells.

REFERENCES:
patent: 4255446 (1981-03-01), Iwao et al.
patent: 4314989 (1982-02-01), Rosen
Shah et al., Chemical Abstracts, vol. 92: 1188.
Kaneko et al., Bulletin Chemical Society (Japan), vol. 37, pp. 242-244, (1964).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cysteine delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cysteine delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cysteine delivery system will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1603967

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.